sevoflurane has been researched along with Arteriosclerosis, Coronary in 7 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND Volatile anesthesia possesses cardioprotective properties, and it is widely used in patients undergoing coronary artery bypass surgery, but no randomized controlled trials (RCTs) are available on the use of sevoflurane-remifentanil versus propofol-remifentanil anesthesia for patients with coronary artery disease (CAD) during noncardiac surgery." | 8.02 | Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease - A Prospective Study Between 2016 and 2017 at a Single Center. ( Dai, Z; Gao, W; Jiang, Y; Li, Y; Lin, J; Lin, M; Wan, Z; Wang, P, 2021) |
| "Patients with coronary artery disease undergoing mitral surgery were randomly allocated to receive either sevoflurane (50 patients) or propofol (50 patients) as main hypnotic." | 5.16 | Sevoflurane vs. propofol in patients with coronary disease undergoing mitral surgery: a randomised study. ( Bignami, E; Fano, G; Franco, A; Gerli, C; Landoni, G; Mizzi, A; Nuzzi, M; Testa, V; Zangrillo, A, 2012) |
| "BACKGROUND Volatile anesthesia possesses cardioprotective properties, and it is widely used in patients undergoing coronary artery bypass surgery, but no randomized controlled trials (RCTs) are available on the use of sevoflurane-remifentanil versus propofol-remifentanil anesthesia for patients with coronary artery disease (CAD) during noncardiac surgery." | 4.02 | Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease - A Prospective Study Between 2016 and 2017 at a Single Center. ( Dai, Z; Gao, W; Jiang, Y; Li, Y; Lin, J; Lin, M; Wan, Z; Wang, P, 2021) |
| "This study was designed to identify attractor modules and further reveal the potential biological processes involving in sevoflurane-induced anesthesia in patients treated with coronary artery bypass graft (CABG) surgery." | 3.85 | Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery. ( Cheng, J; Li, X; Wang, J; Zhang, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Z | 1 |
| Lin, M | 1 |
| Li, Y | 1 |
| Gao, W | 1 |
| Wang, P | 1 |
| Lin, J | 1 |
| Wan, Z | 1 |
| Jiang, Y | 1 |
| Wang, J | 2 |
| Cheng, J | 1 |
| Zhang, C | 1 |
| Li, X | 1 |
| Guerrero Orriach, JL | 1 |
| Galán Ortega, M | 1 |
| Ramirez Fernandez, A | 1 |
| Ramirez Aliaga, M | 1 |
| Moreno Cortes, MI | 1 |
| Ariza Villanueva, D | 1 |
| Florez Vela, A | 1 |
| Alcaide Torres, J | 1 |
| Santiago Fernandez, C | 1 |
| Matute Gonzalez, E | 1 |
| Alsina Marcos, E | 1 |
| Escalona Belmonte, JJ | 1 |
| Rubio Navarro, M | 1 |
| Garrido Sanchez, L | 1 |
| Cruz Mañas, J | 1 |
| Xu, Y | 1 |
| Ma, LL | 1 |
| Zhou, C | 1 |
| Zhang, FJ | 1 |
| Kong, FJ | 1 |
| Wang, WN | 1 |
| Qian, LB | 1 |
| Wang, CC | 1 |
| Liu, XB | 1 |
| Yan, M | 1 |
| Wang, JA | 1 |
| Landoni, G | 2 |
| Turi, S | 1 |
| Bignami, E | 2 |
| Zangrillo, A | 2 |
| Yu, JB | 1 |
| Gong, LR | 1 |
| Wang, M | 1 |
| Zhang, LF | 1 |
| Li, L | 1 |
| Gerli, C | 1 |
| Testa, V | 1 |
| Mizzi, A | 1 |
| Fano, G | 1 |
| Nuzzi, M | 1 |
| Franco, A | 1 |
1 review available for sevoflurane and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Organ protection by volatile anesthetics in non-coronary artery bypass grafting surgery.
Topics: American Heart Association; Anesthetics, Inhalation; Cardiac Surgical Procedures; Cardiotonic Agents | 2009 |
3 trials available for sevoflurane and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Cardioprotective efficacy of sevoflurane vs. propofol during induction and/or maintenance in patients undergoing coronary artery revascularization surgery without pump: A randomized trial.
Topics: Aged; Anesthetics, Intravenous; Cardiotonic Agents; Coronary Artery Disease; Female; Humans; Male; M | 2017 |
Effect of sevoflurane combination with epidural anesthesia on myocardial injury in patients with coronary artery disease undergoing non-cardiac surgery.
Topics: Abdomen; Aged; Anesthesia, Epidural; Anesthetics, Inhalation; Biomarkers; Coronary Artery Disease; E | 2011 |
Sevoflurane vs. propofol in patients with coronary disease undergoing mitral surgery: a randomised study.
Topics: Aged; Anesthetics; Coronary Artery Disease; Female; Humans; Male; Methyl Ethers; Middle Aged; Mitral | 2012 |
3 other studies available for sevoflurane and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease - A Prospective Study Between 2016 and 2017 at a Single Center.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Biomarkers; Clinical Decision-Making; Coronary Artery | 2021 |
Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery.
Topics: Aged; Aged, 80 and over; Algorithms; Anesthesia; Anesthetics, Inhalation; Computational Biology; Cor | 2017 |
Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.
Topics: Anesthetics, Inhalation; Animals; Apoptosis; Cardiotonic Agents; Coronary Artery Disease; Diet; Glyc | 2013 |